Access to care

Bristol Myers Squibb Expands Patient Support Programs to Help Newly Uninsured Patients in the U.S.

Press Release

PRINCETON, N.J., April 7, 2020 /3BL Media/ -Bristol Myers Squibb (NYSE: BMY) today announced an expansion of its existing patient support programs to help eligible unemployed patients in the U.S. who have lost their health insurance due to the COVID-19 pandemic.

The expanded program offers access to any branded Bristol Myers Squibb medicine for free, including some of its most widely prescribed products, as well as those prescribed via telehealth services. The program features:

Pfizer and The Pfizer Foundation Donate $40 Million in Charitable Grants, Expand Product Access and Mobilize Colleagues to Combat COVID-19 Pandemic

Summary: 
  • Building on Pfizer’s longstanding commitment to fight infectious diseases, grants will help address urgent needs of U.S. and global partners on the front lines of the pandemic 

  • Donations complement Pfizer’s COVID-19 R&D investments, as well as collective scientific and philanthropic contributions made by the biopharmaceutical industry

  • U.S. Patient Assistance Program and other programs respond to changing needs of patients and medical community

Press Release
  • Building on Pfizer’s longstanding commitment to fight infectious diseases, grants will help address urgent needs of U.S. and global partners on the front lines of the pandemic 

  • Donations complement Pfizer’s COVID-19 R&D investments, as well as collective scientific and philanthropic contributions made by the biopharmaceutical industry

  • U.S. Patient Assistance Program and other programs respond to changing needs of patients and medical community

An Open Letter from our Chairman and CEO

Blog

Daniel O'Day
 

When the news of the coronavirus first emerged, Gilead immediately began to investigate the potential of remdesivir, a medicine we had been studying for many years as part of our extensive research in antivirals. Remdesivir had never been approved for use but based on what we had learned to date, we knew it might have potential with the novel coronavirus. Since then, we have been working with the greatest sense of urgency and responsibility to determine whether remdesivir does indeed work against COVID-19.

Merck Foundation Launches Five-Year Initiative to Reduce Disparities in HIV Care for Vulnerable and Underserved Southeastern US Communities

Press Release

KENILWORTH, N.J., September 13, 2019 /3BL Media/ --  The Merck Foundation (the Foundation) has launched HIV Care Connect, a $7 million, five-year initiative to help reduce disparities in access to care and improve health outcomes for persons with HIV living in vulnerable and underserved Southeastern U.S. communities.

Gilead Launches HepConnect Initiative to Reduce Hepatitis C Infections in Greater Appalachia

Summary: 
  • Funding will Expand Testing, Harm Reduction Services and Healthcare Infrastructure in States with Highest Infection Rates
  • Harm Reduction Coalition Selected as Lead Grantee to Oversee 5-year Effort to Implement Proven Harm Reduction Strategies in Indiana, Kentucky, North Carolina, Tennessee and West Virginia
Press Release
  • Funding will Expand Testing, Harm Reduction Services and Healthcare Infrastructure in States with Highest Infection Rates
  • Harm Reduction Coalition Selected as Lead Grantee to Oversee 5-year Effort to Implement Proven Harm Reduction Strategies in Indiana, Kentucky, North Carolina, Tennessee and West Virginia

Bringing Medical Treatment to Neonatal Patients Across Africa

Medical Technology Transfer and Services to bring low-cost access to neonatal treatment to 10 African countries
Press Release

HANOI, Vietnam, March 6, 2019 /3BL Media/ – Medical devices designer and manufacturer Medical Technology Transfer and Services (MTTS) has answered the Business Call to Action (BCtA), as the social enterprise commits to delivering access to neonatal treatment for 495,000 low income patients in 10 African countries through the delivery of devices to 200 hospitals. MTTS aims to meet their goal by 2022.

VMware Helps Healthcare Organizations Harness Digital Innovations to Improve the Cost, Quality, and Delivery of Patient Care

Summary: 
  • Moffitt Cancer Center and VITAS Healthcare Showcase Partnership with VMware at HIMSS19
  • VMware Wins 2019 KLAS Category Leader Award for Enterprise Mobility Management and Mobile Device Management
Press Release
  • Moffitt Cancer Center and VITAS Healthcare Showcase Partnership with VMware at HIMSS19
  • VMware Wins 2019 KLAS Category Leader Award for Enterprise Mobility Management and Mobile Device Management

Going the Extra Mile for Patients

Blog

For Darcy Doege, R.N., B.S.N., of the Levine Cancer Institute, finding cancer early in patients means hitting the road.

Darcy is the Program Coordinator for the Lung B.A.S.E.S. 4 Life Program for the Charlotte-based cancer center, which launched the first mobile lung screening unit in the U.S. in 2017. This innovative idea was built to increase the early detection of lung cancer for underserved populations across North and South Carolina, thanks to a grant from the Bristol-Myers Squibb Foundation

Astellas Global Health Foundation Launches

Foundation to Support Improving Access to Health for Underserved Populations
Press Release

Astellas Oncology C3 Prize® Returns for Third Year with Focus on Improving Cancer Care in Underserved Regions of the World

2018 Challenge Will Award a Total of $100,000 in New Grants to Help Reduce the Unequal Burden of Cancer - All Healthcare Innovators Encouraged to Apply
Press Release

TOKYO, June 1, 2018 /3BL Media/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa, Ph.D., "Astellas") have announced the launch of the third annual Astellas Oncology C3 Prize (Changing Cancer Care), a global challenge aimed at inspiring non-treatment ideas that may improve cancer care for patients and their loved ones. This year's challenge will focus on solutions for cancer care in low- and middle-income countries, which bear a disproportionate burden of the global cancer epidemic.1,2,3

Pages

Subscribe to Access to care